Camzyos’ failure in a form of hypertrophic cardiomyopathy dampened its commercial outlook and spurred debate as to whether ...

The American Heart Association recommends calling 911 if any of these symptoms develop, or if a person experiences a sudden loss of responsiveness or can't breathe normally, which are signs of cardiac ...

Bristol Myers Squibb stock skidded late Monday, tugging Cytokinetics lower, after Bristol's drug, Camzyos, failed in a heart disease study.

Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later – can dramatically improve their outlook and even save lives. Patients trea ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

A large European study has raised new concerns about a common medication used to treat high blood pressure. The drug, called ...

Heather Baker, who survived a heart-stopping experience while at work, has advocated tirelessly to instruct others on the ...

(Image Credits: Pixabay) A new study has revealed that semaglutide, a common anti-diabetes drug, could lower risk of cardiovascular complications in diabetics, such as heart attacks and strokes ...

While more people than ever are running marathons in the US, the risk of dying from a heart ... cardiac arrests remained unchanged, their chance for survival is twice what it was in the past. Now, far ...

In a statement, the German maker of drugs and agricultural supplies said it would bring Beyonttra, also known as acoramidis, to market to treat a condition that results in heart failure.